PMOS is a multisystem condition, so the old tendency to treat every case as insulin resistance first misses a big part of the clinical picture. Some patients present with clear hyperinsulinemia, while others have more ovulatory dysfunction, androgen excess, inflammatory features, or neuroendocrine disruption without obvious metabolic markers. That is why phenotype based thinking matters.

The clinical takeaway is simple. Insulin resistance is common in PMOS, but it is not universal. It also develops gradually, so fasting glucose can look normal long before insulin becomes obviously elevated. If you only screen one way, you can miss the real driver of the case.

Why The Name Matters Clinically

PMOS stands for Polyendocrine Metabolic Ovarian Syndrome, and the rename reflects the condition’s broader endocrine and metabolic scope. That matters for practitioners because it pushes us to think beyond the ovaries and beyond reproduction alone. We need to assess the HPO axis, insulin signaling, androgen balance, inflammation, and cycle function together.[nytimes]

This is especially important in cases that do not fit the classic insulin resistant phenotype. Patients may still have irregular ovulation, long follicular phases, anovulation, acne, hirsutism, or elevated androgens with normal fasting insulin. The diagnosis is broader than one lab pattern.

Related Post: PCOS Is Now PMOS: What the 2026 Name Change Means for Fertility Acupuncturists

Lab Strategy

Fasting insulin is a useful tool, but it is not a stand alone answer. It should be considered alongside fasting glucose, HbA1c, and, when appropriate, OGTT because fasting glucose alone can miss dysglycemia in PMOS. In practice, the lab picture should be interpreted in context with the patient’s symptom profile and cycle data.

Other useful labs often include LH, FSH, total and free testosterone, DHEA S, AMH, and sometimes prolactin and thyroid testing depending on the presentation. For some patients, the normal lab is actually the clue that insulin is not the dominant mechanism. That is when you need to pivot away from default metabolic protocols and look for the more accurate driver.[yalemedicine]

Pattern Recognition In Clinic

One of the most common mistakes is assuming every PMOS patient needs the same metabolic intervention intensity. In some cases, blood sugar support is central. In others, it is secondary to a more dominant ovulatory or adrenal androgen pattern. That means intake, tongue, pulse, labs, and cycle tracking all matter in the treatment plan.[pmc.ncbi.nlm.nih]

In AFAM terms, your treatment should follow the phenotype:

• Metabolic dominant: focus more heavily on insulin modulation, blood sugar stability, and inflammatory load.
• Ovulatory dominant: prioritize follicular progression, HPO support, and cycle regulation.
• Adrenal androgen dominant: expect a different pattern and do not overfocus on glucose if it is not the main driver.

Treatment Implications

Acupuncture can be tailored to the dominant pattern rather than used as a generic PMOS protocol. The point strategy, frequency, and lifestyle recommendations should reflect whether you are primarily addressing insulin signaling, ovulatory dysfunction, luteal support, or mixed presentation. That is where clinical precision changes outcomes.

The biggest teaching point is this. PMOS is not one disease with one root. It is a syndrome with multiple possible dominant mechanisms, and our job is to identify which one is leading the case. When we do that well, our treatment becomes more effective, more collaborative, and much easier for patients to understand.

Join us inside AFAM and let’s build your specialty together

Related Post: Your Next Chapter in Fertility Acupuncture: Introducing the AFAM Mentorship

About the author Emily Marson, L.Ac. Emily is the founder of Aphrodite Fertility Acupuncture in San Diego, California. She specializes in complex reproductive cases, combining advanced fertility acupuncture with mitochondrial health protocols, precision nutrition, and a deep knowledge of both Eastern and Western reproductive medicine. Located at 2970 5th Ave, Suite 320, San Diego, CA 92102.